Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker LTRN
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | Lee Troy Schalop Director | LTRN Lantern Pharma Inc. | Buy | 48,544 | $2.06 | $100.0K Buy | Form 4 ↗ |
| May 12, 2026 | D. Jeffrey Keyser Director | LTRN Lantern Pharma Inc. | Buy | 48,544 | $2.06 | $100.0K Buy | Form 4 ↗ |
| Jun 13, 2025 | BIOS Fund II QP, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 4,354 | $3.09 | $13.5K Sale | Form 4 ↗ |
| Jun 13, 2025 | BIOS Fund II QP, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 14,218 | $3.09 | $43.9K Sale | Form 4 ↗ |
| Jun 13, 2025 | BIOS Fund II QP, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 1,903 | $3.09 | $5,880 Sale | Form 4 ↗ |
| Jun 13, 2025 | BIOS Fund II QP, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 12,319 | $3.09 | $38.1K Sale | Form 4 ↗ |
| Jun 13, 2025 | BIOS Fund II QP, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 7,206 | $3.09 | $22.3K Sale | Form 4 ↗ |
| Jun 13, 2025 | BP Directors, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 4,354 | $3.09 | $13.5K Sale | Form 4 ↗ |
| Jun 13, 2025 | BP Directors, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 14,218 | $3.09 | $43.9K Sale | Form 4 ↗ |
| Jun 13, 2025 | BP Directors, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 1,903 | $3.09 | $5,880 Sale | Form 4 ↗ |
| Jun 13, 2025 | BP Directors, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 12,319 | $3.09 | $38.1K Sale | Form 4 ↗ |
| Jun 13, 2025 | BP Directors, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 7,206 | $3.09 | $22.3K Sale | Form 4 ↗ |
| Jun 12, 2025 | BIOS Fund I, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 6,601 | $3.38 | $22.3K Sale | Form 4 ↗ |
| Jun 12, 2025 | BIOS Fund I, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 21,557 | $3.38 | $72.9K Sale | Form 4 ↗ |
| Jun 12, 2025 | BIOS Fund I, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 2,886 | $3.38 | $9,755 Sale | Form 4 ↗ |
| Jun 12, 2025 | BIOS Fund I, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 18,678 | $3.38 | $63.1K Sale | Form 4 ↗ |
| Jun 12, 2025 | BIOS Fund I, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 10,925 | $3.38 | $36.9K Sale | Form 4 ↗ |
| Jun 12, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 6,601 | $3.38 | $22.3K Sale | Form 4 ↗ |
| Jun 12, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 21,557 | $3.38 | $72.9K Sale | Form 4 ↗ |
| Jun 12, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 2,886 | $3.38 | $9,755 Sale | Form 4 ↗ |
| Jun 12, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 18,678 | $3.38 | $63.1K Sale | Form 4 ↗ |
| Jun 12, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 10,925 | $3.38 | $36.9K Sale | Form 4 ↗ |
| Jun 11, 2025 | BIOS Fund I, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 103 | $3.40 | $350 Sale | Form 4 ↗ |
| Jun 11, 2025 | BIOS Fund I, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 338 | $3.40 | $1,149 Sale | Form 4 ↗ |
| Jun 11, 2025 | BIOS Fund I, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 45 | $3.40 | $153 Sale | Form 4 ↗ |
| Jun 11, 2025 | BIOS Fund I, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 293 | $3.40 | $996 Sale | Form 4 ↗ |
| Jun 11, 2025 | BIOS Fund I, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 171 | $3.40 | $581 Sale | Form 4 ↗ |
| Jun 11, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 103 | $3.40 | $350 Sale | Form 4 ↗ |
| Jun 11, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 338 | $3.40 | $1,149 Sale | Form 4 ↗ |
| Jun 11, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 45 | $3.40 | $153 Sale | Form 4 ↗ |
| Jun 11, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 293 | $3.40 | $996 Sale | Form 4 ↗ |
| Jun 11, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 171 | $3.40 | $581 Sale | Form 4 ↗ |
| Jun 10, 2025 | BIOS Fund I, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 2 | $3.40 | $6.8 Sale | Form 4 ↗ |
| Jun 10, 2025 | BIOS Fund I, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 5 | $3.40 | $17 Sale | Form 4 ↗ |
| Jun 10, 2025 | BIOS Fund I, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 1 | $3.40 | $3.4 Sale | Form 4 ↗ |
| Jun 10, 2025 | BIOS Fund I, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 5 | $3.40 | $17 Sale | Form 4 ↗ |
| Jun 10, 2025 | BIOS Fund I, LP 10% owner | LTRN Lantern Pharma Inc. | Sale | 3 | $3.40 | $10.2 Sale | Form 4 ↗ |
| Jun 10, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 2 | $3.40 | $6.8 Sale | Form 4 ↗ |
| Jun 10, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 5 | $3.40 | $17 Sale | Form 4 ↗ |
| Jun 10, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 1 | $3.40 | $3.4 Sale | Form 4 ↗ |
| Jun 10, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 5 | $3.40 | $17 Sale | Form 4 ↗ |
| Jun 10, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 3 | $3.40 | $10.2 Sale | Form 4 ↗ |
| May 29, 2025 | BIOS Advisors GP, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 2,199 | $3.03 | $6,663 Sale | Form 4 ↗ |
| May 29, 2025 | BIOS Advisors GP, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 7,180 | $3.03 | $21.8K Sale | Form 4 ↗ |
| May 29, 2025 | BIOS Advisors GP, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 961 | $3.03 | $2,912 Sale | Form 4 ↗ |
| May 29, 2025 | BIOS Advisors GP, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 6,221 | $3.03 | $18.8K Sale | Form 4 ↗ |
| May 29, 2025 | BIOS Advisors GP, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 3,639 | $3.03 | $11.0K Sale | Form 4 ↗ |
| May 29, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 2,199 | $3.03 | $6,663 Sale | Form 4 ↗ |
| May 29, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 7,180 | $3.03 | $21.8K Sale | Form 4 ↗ |
| May 29, 2025 | Cavu Advisors, LLC 10% owner | LTRN Lantern Pharma Inc. | Sale | 961 | $3.03 | $2,912 Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:36 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances